News
Discover the latest news and developments in AI and machine learning happening in the image-guided therapy (IGT) sector in Canada.
Sonic Incytes is making liver screening more accessible
Sonic Incytes, a Canadian artificial intelligence (AI)-assisted medical imaging company based out of Vancouver, British Columbia, is looking to change the way liver disease is screened and monitored globally. Their flagship, FDA cleared device, Velacur™, is revolutionizing the diagnosis and management of chronic liver disease. Their proprietary technology that grew into Velacur was originally developed by researchers at the University of British Columbia (UBC).
Network News
Velacur: Providing patients with early detection of liver disease
One in five Canadians have nonalcoholic fatty liver disease (NAFLD), which can...
INOVAIT opens new funding round for image-guided therapy projects
(October 12, 2022 – Toronto, ON) – INOVAIT, the pan-Canadian network supported by the Government of Canada’s Strategic...
INOVAIT announces latest recipients of funding for artificial intelligence and image-guided therapy projects
September 20, 2022 | Toronto, ON – INOVAIT, the pan-Canadian network supported by the Government of Canada’s Strategic...
INOVAIT Announces First Round of Successful Pilots
TORONTO, ON, January 10th, 2022 - INOVAIT is thrilled to announce that 28 healthcare technology companies and...
IGT Lecture Series
Regulating AI in Image-Guided Therapy
Follow INOVAIT on Social Media
The Network in the Press
